tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VRTX Stock Latest News

Vertex says JOURNAVX demonstrates ‘effective’ pain management in study
The FlyVertex says JOURNAVX demonstrates ‘effective’ pain management in study
18h ago
VRTX
Absci appoints Ransi Somaratne as CMO
PremiumThe Fly
Absci appoints Ransi Somaratne as CMO
3d ago
ABSI
VRTX
Vertex Expands VX-548 Safety Profile With New Breastfeeding Study
PremiumCompany Announcements
Vertex Expands VX-548 Safety Profile With New Breastfeeding Study
7d ago
VRTX
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
PremiumMarket News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
15d ago
BIB
CRBU
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
PremiumMarket News
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
17d ago
IBB
UPB
Crispr Therapeutics price target raised to $33 from $32 at Morgan Stanley
PremiumThe FlyCrispr Therapeutics price target raised to $33 from $32 at Morgan Stanley
17d ago
CRSP
VRTX
Vertex Pharmaceuticals price target raised to $441 from $411 at Canaccord
Premium
The Fly
Vertex Pharmaceuticals price target raised to $441 from $411 at Canaccord
17d ago
VRTX
Vertex Pharmaceuticals price target raised to $607 from $606 at Barclays
Premium
The Fly
Vertex Pharmaceuticals price target raised to $607 from $606 at Barclays
17d ago
VRTX
Vertex Pharmaceuticals price target raised to $591 from $518 at H.C. Wainwright
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $591 from $518 at H.C. Wainwright
17d ago
VRTX
Vertex Pharmaceuticals Signals Confident Growth Beyond CF
PremiumCompany Announcements
Vertex Pharmaceuticals Signals Confident Growth Beyond CF
20d ago
VRTX
Vertex Pharmaceuticals price target raised to $570 from $564 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $570 from $564 at Morgan Stanley
21d ago
VRTX
Vertex Pharmaceuticals price target raised to $558 from $495 at Scotiabank
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $558 from $495 at Scotiabank
21d ago
VRTX
Vertex Pharmaceuticals price target lowered to $541 from $546 at RBC Capital
PremiumThe FlyVertex Pharmaceuticals price target lowered to $541 from $546 at RBC Capital
21d ago
VRTX
Vertex Pharmaceuticals price target raised to $577 from $572 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target raised to $577 from $572 at Bernstein
21d ago
VRTX
Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI
Premium
The Fly
Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI
21d ago
CRSP
VRTX
Vertex Pharmaceuticals price target raised to $590 from $485 at Cantor Fitzgerald
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $590 from $485 at Cantor Fitzgerald
21d ago
VRTX
Balancing Solid CF Revenue With Kidney Pipeline Uncertainty: Why Stringer Maintains a Hold on Vertex
PremiumRatings
Balancing Solid CF Revenue With Kidney Pipeline Uncertainty: Why Stringer Maintains a Hold on Vertex
21d ago
VRTX
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
21d ago
VRTX
Vertex Pharmaceuticals price target raised to $466 from $445 at Stifel
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $466 from $445 at Stifel
21d ago
VRTX
Vertex Pharmaceuticals price target raised to $518 from $478 at H.C. Wainwright
PremiumThe FlyVertex Pharmaceuticals price target raised to $518 from $478 at H.C. Wainwright
21d ago
VRTX
Vertex Pharmaceuticals reports Q4 adjusted EPS $5.03, consensus $5.15
Premium
The Fly
Vertex Pharmaceuticals reports Q4 adjusted EPS $5.03, consensus $5.15
22d ago
VRTX
Vertex Pharmaceuticals sees FY26 revenue $12.95B-$13.1B, consensus $13B
Premium
The Fly
Vertex Pharmaceuticals sees FY26 revenue $12.95B-$13.1B, consensus $13B
22d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >